Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments

A. Corsini, C. H. Spilman, T. L. Innerarity, K. S. Arnold, S. C. Rall, J. K. Boyles, R. W. Mahley

Research output: Contribution to journalArticle

Abstract

Apolipoprotein (apo) B-100, the protein constituent of low density lipoproteins (LDL), is the determinant responsible for LDL binding to the apoB,E(LDL) receptor on cells. The current study was designed to identify the region(s) of apoB-100 that interact with the apoB,E(LDL) receptor. Apolipoprotein B-100 was fragmented by thrombin digestion, and the isolated fragments (T2, T3, T4) were recombined with cholesterol-induced canine high density lipoproteins (HDL(c)). Before the recombination, the receptor binding activity of apoE of the HDL(c) was abolished by reductive methylation and extensive trypsin treatment. This treatment permitted almost complete replacement of the small residual apoE fragments by the large apoB fragments. Recombinant apoB particles were isolated by ultracentrifugation and tested for binding to receptors on cultured human fibroblasts. The recombinant particles had chemical and physical properties similar to those of native HDL(c). Recombinants of both the whole thrombolytic digest and of isolated fragments displayed specific binding to the apoB,E (LDL) receptor. Anti-apoB,E(LDL) receptor antibodies abolished 90% of the binding, and there was almost no specific binding to receptor-negative fibroblasts or to cells in which the receptors had been down-regulated. The binding of apoB-100 recombinants to the receptor also demonstrated calcium dependency; in addition, the surface binding of the recombinants was released by polyanionic compounds. All these recombinants had binding affinities comparable to one another but less than that of native LDL. Although T2, T3 and T4 recombinants can all bind specifically to the apoB,E(LDL) receptor, it remains to be established whether their activity represents physiologically relevant binding. Nevertheless, the present findings illustrate the potential of the recombinant method using HDL(c) lipids to reconstitute biological activity.

Original languageEnglish
Pages (from-to)1410-1423
Number of pages14
JournalJournal of Lipid Research
Volume28
Issue number12
Publication statusPublished - 1987

Fingerprint

Apolipoprotein B-100
Apolipoproteins B
LDL Receptors
Lipids
LDL Lipoproteins
Fibroblasts
Methylation
Ultracentrifugation
Apolipoproteins E
HDL Lipoproteins
Bioactivity
Thrombin
Trypsin
Chemical properties
Genetic Recombination
Canidae
Digestion
Physical properties
Cholesterol
Calcium

ASJC Scopus subject areas

  • Endocrinology

Cite this

Corsini, A., Spilman, C. H., Innerarity, T. L., Arnold, K. S., Rall, S. C., Boyles, J. K., & Mahley, R. W. (1987). Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments. Journal of Lipid Research, 28(12), 1410-1423.

Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments. / Corsini, A.; Spilman, C. H.; Innerarity, T. L.; Arnold, K. S.; Rall, S. C.; Boyles, J. K.; Mahley, R. W.

In: Journal of Lipid Research, Vol. 28, No. 12, 1987, p. 1410-1423.

Research output: Contribution to journalArticle

Corsini, A, Spilman, CH, Innerarity, TL, Arnold, KS, Rall, SC, Boyles, JK & Mahley, RW 1987, 'Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments', Journal of Lipid Research, vol. 28, no. 12, pp. 1410-1423.
Corsini A, Spilman CH, Innerarity TL, Arnold KS, Rall SC, Boyles JK et al. Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments. Journal of Lipid Research. 1987;28(12):1410-1423.
Corsini, A. ; Spilman, C. H. ; Innerarity, T. L. ; Arnold, K. S. ; Rall, S. C. ; Boyles, J. K. ; Mahley, R. W. / Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments. In: Journal of Lipid Research. 1987 ; Vol. 28, No. 12. pp. 1410-1423.
@article{b5bb45b7ea864fcfba9b744c31ab1a1b,
title = "Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments",
abstract = "Apolipoprotein (apo) B-100, the protein constituent of low density lipoproteins (LDL), is the determinant responsible for LDL binding to the apoB,E(LDL) receptor on cells. The current study was designed to identify the region(s) of apoB-100 that interact with the apoB,E(LDL) receptor. Apolipoprotein B-100 was fragmented by thrombin digestion, and the isolated fragments (T2, T3, T4) were recombined with cholesterol-induced canine high density lipoproteins (HDL(c)). Before the recombination, the receptor binding activity of apoE of the HDL(c) was abolished by reductive methylation and extensive trypsin treatment. This treatment permitted almost complete replacement of the small residual apoE fragments by the large apoB fragments. Recombinant apoB particles were isolated by ultracentrifugation and tested for binding to receptors on cultured human fibroblasts. The recombinant particles had chemical and physical properties similar to those of native HDL(c). Recombinants of both the whole thrombolytic digest and of isolated fragments displayed specific binding to the apoB,E (LDL) receptor. Anti-apoB,E(LDL) receptor antibodies abolished 90{\%} of the binding, and there was almost no specific binding to receptor-negative fibroblasts or to cells in which the receptors had been down-regulated. The binding of apoB-100 recombinants to the receptor also demonstrated calcium dependency; in addition, the surface binding of the recombinants was released by polyanionic compounds. All these recombinants had binding affinities comparable to one another but less than that of native LDL. Although T2, T3 and T4 recombinants can all bind specifically to the apoB,E(LDL) receptor, it remains to be established whether their activity represents physiologically relevant binding. Nevertheless, the present findings illustrate the potential of the recombinant method using HDL(c) lipids to reconstitute biological activity.",
author = "A. Corsini and Spilman, {C. H.} and Innerarity, {T. L.} and Arnold, {K. S.} and Rall, {S. C.} and Boyles, {J. K.} and Mahley, {R. W.}",
year = "1987",
language = "English",
volume = "28",
pages = "1410--1423",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments

AU - Corsini, A.

AU - Spilman, C. H.

AU - Innerarity, T. L.

AU - Arnold, K. S.

AU - Rall, S. C.

AU - Boyles, J. K.

AU - Mahley, R. W.

PY - 1987

Y1 - 1987

N2 - Apolipoprotein (apo) B-100, the protein constituent of low density lipoproteins (LDL), is the determinant responsible for LDL binding to the apoB,E(LDL) receptor on cells. The current study was designed to identify the region(s) of apoB-100 that interact with the apoB,E(LDL) receptor. Apolipoprotein B-100 was fragmented by thrombin digestion, and the isolated fragments (T2, T3, T4) were recombined with cholesterol-induced canine high density lipoproteins (HDL(c)). Before the recombination, the receptor binding activity of apoE of the HDL(c) was abolished by reductive methylation and extensive trypsin treatment. This treatment permitted almost complete replacement of the small residual apoE fragments by the large apoB fragments. Recombinant apoB particles were isolated by ultracentrifugation and tested for binding to receptors on cultured human fibroblasts. The recombinant particles had chemical and physical properties similar to those of native HDL(c). Recombinants of both the whole thrombolytic digest and of isolated fragments displayed specific binding to the apoB,E (LDL) receptor. Anti-apoB,E(LDL) receptor antibodies abolished 90% of the binding, and there was almost no specific binding to receptor-negative fibroblasts or to cells in which the receptors had been down-regulated. The binding of apoB-100 recombinants to the receptor also demonstrated calcium dependency; in addition, the surface binding of the recombinants was released by polyanionic compounds. All these recombinants had binding affinities comparable to one another but less than that of native LDL. Although T2, T3 and T4 recombinants can all bind specifically to the apoB,E(LDL) receptor, it remains to be established whether their activity represents physiologically relevant binding. Nevertheless, the present findings illustrate the potential of the recombinant method using HDL(c) lipids to reconstitute biological activity.

AB - Apolipoprotein (apo) B-100, the protein constituent of low density lipoproteins (LDL), is the determinant responsible for LDL binding to the apoB,E(LDL) receptor on cells. The current study was designed to identify the region(s) of apoB-100 that interact with the apoB,E(LDL) receptor. Apolipoprotein B-100 was fragmented by thrombin digestion, and the isolated fragments (T2, T3, T4) were recombined with cholesterol-induced canine high density lipoproteins (HDL(c)). Before the recombination, the receptor binding activity of apoE of the HDL(c) was abolished by reductive methylation and extensive trypsin treatment. This treatment permitted almost complete replacement of the small residual apoE fragments by the large apoB fragments. Recombinant apoB particles were isolated by ultracentrifugation and tested for binding to receptors on cultured human fibroblasts. The recombinant particles had chemical and physical properties similar to those of native HDL(c). Recombinants of both the whole thrombolytic digest and of isolated fragments displayed specific binding to the apoB,E (LDL) receptor. Anti-apoB,E(LDL) receptor antibodies abolished 90% of the binding, and there was almost no specific binding to receptor-negative fibroblasts or to cells in which the receptors had been down-regulated. The binding of apoB-100 recombinants to the receptor also demonstrated calcium dependency; in addition, the surface binding of the recombinants was released by polyanionic compounds. All these recombinants had binding affinities comparable to one another but less than that of native LDL. Although T2, T3 and T4 recombinants can all bind specifically to the apoB,E(LDL) receptor, it remains to be established whether their activity represents physiologically relevant binding. Nevertheless, the present findings illustrate the potential of the recombinant method using HDL(c) lipids to reconstitute biological activity.

UR - http://www.scopus.com/inward/record.url?scp=0023543411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023543411&partnerID=8YFLogxK

M3 - Article

C2 - 2828500

AN - SCOPUS:0023543411

VL - 28

SP - 1410

EP - 1423

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 12

ER -